The acquisition battle between global pharmaceutical giants Pfizer and Novo Nordisk over the bio company Metsera is heating ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the Best Beaten Down Growth Stocks to Buy According to Analysts.

Health Biotech Limited (Health Biotech), a research and development-driven pharmaceutical company from India, successfully ...

Boston-based biotech firm Manifold Bio announced on Monday that it will partner with Swiss pharmaceutical giant Roche to develop a drug for neurological disease using technology driven by artificial ...

But Doustdar also seems to recognize what he has in Novo Nordisk, the 100-year-old pharma that brought insulin to the masses, ...

Electra Therapeutics has garnered the funds it needs to complete a pivotal trial of its lead drug, angling to become the ...

Novo Nordisk A/S to scupper its acquisition of Metsera Inc., with an unsolicited $9 billion offer for the anti-obesity specialist. That trumps Pfizer’s agreed bid made in September, which valued New ...

The discussion turned to vital role of the human element despite AI’s increasing integration into recruitment. Recruiting leaders use AI to reduce administrative tasks, thereby giving them free time ...

In the lead up to this year's Sustainable Packaging Summit, taking place in Utrecht on 10th-12th November, we hear from Sustainability Awards finalist Ambipar about its biocapsule packaging, designed ...

OncoZenge AB (publ) ("OncoZenge" or "the Company") today announced the interim report for the third quarter of 2025. The Company reports receipt of investment funds for its European Phase III program, ...